Search Results - Philip J. Budge
- Showing 1 - 13 results of 13
-
1
Adverse events following single dose treatment of lymphatic filariasis: Observations from a review of the literature. by Philip J Budge, Carly Herbert, Britt J Andersen, Gary J Weil
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
2
Accuracy of Coverage Survey Recall following an Integrated Mass Drug Administration for Lymphatic Filariasis, Schistosomiasis, and Soil-Transmitted Helminthiasis. by Philip J Budge, Edmond Sognikin, Amanda Akosa, Els M Mathieu, Michael Deming
Published 2016Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
3
Impact of community-based lymphedema management on perceived disability among patients with lymphatic filariasis in Orissa State, India. by Philip J Budge, Kristen M Little, Katherine E Mues, Erin D Kennedy, Aiysha Prakash, Jonathan Rout, LeAnne M Fox
Published 2013Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
4
Portable infrared imaging for longitudinal limb volume monitoring in patients with lymphatic filariasis. by Celia Zhou, Channa Yahathugoda, Lalindi De Silva, Upeksha Rathnapala, Grant Owen, Mirani Weerasooriya, Ramakrishna U Rao, Gary J Weil, Philip J Budge
Published 2019Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
5
Impact of a community-based lymphedema management program on episodes of Adenolymphangitis (ADLA) and lymphedema progression--Odisha State, India. by Katherine E Mues, Michael Deming, David G Kleinbaum, Philip J Budge, Mitch Klein, Juan S Leon, Aishya Prakash, Jonathan Rout, LeAnne M Fox
Published 2014Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
6
Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections. by Sarah E Greene, Kerstin Fischer, Young-Jun Choi, Kurt C Curtis, Philip J Budge, Makedonka Mitreva, Christopher L King, Peter U Fischer, Gary J Weil
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
7
Characterization of a novel microfilarial antigen for diagnosis of Wuchereria bancrofti infections by Sarah E. Greene, Kerstin Fischer, Young-Jun Choi, Kurt C. Curtis, Philip J. Budge, Makedonka Mitreva, Christopher L. King, Peter U. Fischer, Gary J. Weil
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
8
Identification and characterization of Loa loa antigens responsible for cross-reactivity with rapid diagnostic tests for lymphatic filariasis. by Marla I Hertz, Hugues Nana-Djeunga, Joseph Kamgno, Abdel Jelil Njouendou, Valerine Chawa Chunda, Samuel Wanji, Amy Rush, Peter U Fischer, Gary J Weil, Philip J Budge
Published 2018Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
9
Clinical and occupational risk factors for coronavirus disease 2019 (COVID-19) in healthcare personnel by Jennie H. Kwon, Philip J. Budge, Caroline A. O'Neil, Kate Peacock, Eva M. Aagaard, Victoria J. Fraser, Margaret A. Olsen, Hilary Babcock, for the CDC Prevention Epicenters Program
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
10
Safety and tolerability of moxidectin and ivermectin combination treatments for lymphatic filariasis in Côte d'Ivoire: A randomized controlled superiority study. by Catherine M Bjerum, Benjamin G Koudou, Allassane F Ouattara, Daphne Lew, Charles W Goss, Pascal T Gabo, Christopher L King, Peter U Fischer, Gary J Weil, Philip J Budge
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
11
Pharmacokinetics of Moxidectin combined with Albendazole or Albendazole plus Diethylcarbamazine for Bancroftian Filariasis. by Yashpal S Chhonker, Catherine Bjerum, Veenu Bala, Allassane F Ouattara, Benjamin G Koudou, Toki P Gabo, Abdullah Alshehri, Abdoulaye Meïté, Peter U Fischer, Gary J Weil, Christopher L King, Philip J Budge, Daryl J Murry
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
12
Seroprevalence of severe acute respiratory coronavirus virus 2 (SARS-CoV-2) antibodies among healthcare personnel in the Midwestern United States, September 2020-April 2021 by Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O'Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret A. Olsen, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters
Published 2023Call Number: Loading…Connect to this object online.
Located: Loading…
Book -
13
Antibodies in healthcare personnel following severe acute respiratory syndrome coronavirus virus 2 (SARS-CoV-2) infection by Rachel E. Bosserman, Christopher W. Farnsworth, Caroline A. O'Neil, Candice Cass, Daniel Park, Claire Ballman, Meghan A. Wallace, Emily Struttmann, Henry Stewart, Olivia Arter, Kate Peacock, Victoria J. Fraser, Philip J. Budge, Margaret A. Olsen, Carey-Ann D. Burnham, Hilary M. Babcock, Jennie H. Kwon, for the CDC Prevention Epicenters
Published 2022Call Number: Loading…Connect to this object online.
Located: Loading…
Book